Latest papers

Association of the G894T polymorphism of the endothelial nitric oxide synthase gene with diabetic foot syndrome foot ulcer, diabetic complications, and comorbid vascular diseases: a Turkish case-control study.

Coagulation profile in diabetes and its association with diabetic microvascular complications.

Aspirin for the prevention of cardiovascular morbidity.

Diabetic specific aspects in antithrombotic therapy in patients with coronary artery disease.

A race for RAGE ligands.

Peripheral arterial disease in community-based patients with diabetes in Singapore: Results from a Primary Healthcare Study.

Metabolic syndrome exacerbating ankle-brachial index in asian type 2 diabetic patients.

The role of epigenetics in the pathology of diabetic complications.

Post-challenge hyperglycaemia is strongly associated with future macrovascular events and total mortality in angiographied coronary patients.

Post-challenge hyperglycaemia is strongly associated with future macrovascular events and total mortality in angiographied coronary patients.

Post-challenge hyperglycaemia is strongly associated with future macrovascular events and total mortality in angiographied coronary patients.

Post-challenge hyperglycaemia is strongly associated with future macrovascular events and total mortality in angiographied coronary patients.

Post-challenge hyperglycaemia is strongly associated with future macrovascular events and total mortality in angiographied coronary patients.

Post-challenge hyperglycaemia is strongly associated with future macrovascular events and total mortality in angiographied coronary patients.

Post-challenge hyperglycaemia is strongly associated with future macrovascular events and total mortality in angiographied coronary patients.

Post-challenge hyperglycaemia is strongly associated with future macrovascular events and total mortality in angiographied coronary patients.

Post-challenge hyperglycaemia is strongly associated with future macrovascular events and total mortality in angiographied coronary patients.

Post-challenge hyperglycaemia is strongly associated with future macrovascular events and total mortality in angiographied coronary patients.

Post-challenge hyperglycaemia is strongly associated with future macrovascular events and total mortality in angiographied coronary patients.

Post-challenge hyperglycaemia is strongly associated with future macrovascular events and total mortality in angiographied coronary patients.